Boston Partners’s Clorox CLX Stock Holding History

Boston Partners’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,391	Closed	-$1M	–	717
2018 Q2	$1M	Buy	+7,391	New	+$912K	﹤0.01%	742

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boston Partners's CLX Position: Q3 2018 in Review

Boston Partners sold out of Clorox (CLX) in Q3 2018, closing a stake of 7,391 shares — an estimated $1M sold.

Boston Partners first reported a position in CLX in Q2 2018 and held it in 1 quarter. The position peaked at $1M in Q2 2018. 933 funds tracked by Wall St. Rank hold CLX as of Q3 2018.

Boston Partners reported no remaining Clorox position as of Q3 2018 after selling out during the quarter.
Boston Partners sold 7,391 Clorox shares in Q3 2018, an estimated $1M.
Boston Partners first reported a position in Clorox in Q2 2018 and held it in 1 quarter.
Boston Partners's Clorox position peaked at $1M in Q2 2018.
933 funds tracked by Wall St. Rank held Clorox as of Q3 2018.

Based on Boston Partners's 13F filing for Q3 2018, filed 14 Nov 2018.